[1]
E. Nowicka, “Poly ADP-ribose polymerase (PARP) inhibitors - new therapeutic strategies in Acute Myeloid Leukemia: a literature review”, J Educ Health Sport, vol. 13, no. 2, pp. 104–109, Dec. 2022.